Life science News and Research

RSS

Harvard Apparatus/ Hugo Sachs Elektronik business collaborates to develop lung regeneration bioreactor

Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, announces that its Harvard Apparatus / Hugo Sachs Elektronik business collaborated with Dr. Harald Ott and Massachusetts General Hospital (MGH) to design and manufacture a novel bioreactor that was used to grow a functional lung. The lung was subsequently transplanted into a rat.

21 Jul 2010

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.

20 Jul 2010

Meridian Bioscience completes acquisition of Bioline group of companies

Meridian Bioscience, Inc., Cincinnati, Ohio announces that effective today it will have completed the purchase of all the outstanding capital stock of the Bioline group of companies consisting of Bioline Ltd (UK), Bioline GmbH (Germany), Bioline (Aust) Pty Ltd (Australia), Bioline Reagents Ltd, and Bioline USA, Inc for $23.3 million in cash on hand.

20 Jul 2010

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

Bionas GmbH announces the launch of its new Bionas® adcon reader for impedance-based, cellular analysis. The Bionas adcon reader technology is based on real-time monitoring of cellular impedance, thus giving real-time data about cell adhesion, membrane integrity, cellular morphology and cell proliferation for applications in toxicology, oncology, receptor signaling as well as the quality management of cells.

19 Jul 2010

EndoStim raises $6M in Series B equity financing round

EndoStim, Inc., a medical device company developing minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, today announced it has raised $6 million in Series B equity financing. Santé Ventures, a life science venture capital firm, led the round and was joined by the Prolog Ventures, Vectis Healthcare & Life Sciences Fund II and returning angel investors.

19 Jul 2010

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

Millipore Corporation exchanges common stock with Merck

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that Merck KGaA ("Merck") has completed its acquisition of Millipore (the "Acquisition") as of July 14, 2010. As part of the transaction, all issued and outstanding shares of Millipore common stock were exchanged for $107 per share in cash.

17 Jul 2010

Ligand Pharmaceuticals announces launch of redesigned Web site

Ligand Pharmaceuticals Incorporated announces the launch of its completely redesigned Web site: www.ligand.com. The new Web site is designed as a comprehensive resource for investors, prospective corporate partners and the life science community to learn more about Ligand's business model, robust pipeline, high-profile partnerships and innovative technology.

15 Jul 2010

Merck acquires Millipore for $7.0 billion

Merck KGaA, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation, a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately $7.0 billion. Merck agreed to acquire Millipore on February 28, 2010 for $107 in cash per share of Millipore common stock.

15 Jul 2010

Maven Semantic releases updates to Biotechnology research database

Maven Semantic (http://www.mavensemantic.com) announces updates to their Biotechnology research database.

14 Jul 2010

Gerresheimer second-quarter group revenues increase by 6.8%

Gerresheimer AG, one of the leading worldwide suppliers to the pharma and healthcare industry, remained on its growth path during the second quarter of the financial year 2010. "Our business developed very well in the second quarter. The demand for our products in the pharma industry has grown and there has also been an improvement recently in the Cosmetics and Life Science Research businesses," says Uwe Rohrhoff, the new CEO of Gerresheimer AG since June 22, 2010.

14 Jul 2010

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Zogenix, Inc., a privately held pharmaceutical company, announced that it has secured a $35 million debt facility led by Oxford Finance Corporation which also included Silicon Valley Bank. The facility consists of a $25 million term loan and a $10 million revolving line of credit. Concurrently, all existing Zogenix investors, including Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas, McNerney & Partners, Abingworth Management, and Chicago Growth Partners, have provided an additional $15 million investment.

14 Jul 2010

Cognis exclusively licensed two new active ingredients from IMD

Specialty chemicals supplier Cognis and InterMed Discovery, a world class natural product lead-discovery company, are continuing their strategic cooperation: Cognis has now exclusively licensed two new active ingredients for weight management and cognitive performance from IMD, further expanding the company's innovation pipeline.

13 Jul 2010

HighRes Biosolutions to provide high-throughput screening automation to Rigel

HighRes Biosolutions, the leader in laboratory automation solutions for life science, announced today that it will be providing high-throughput screening automation to Rigel Pharmaceuticals, a South San Francisco, California-based clinical-stage drug development company.

13 Jul 2010

Affygility Solutions releases new version of Affytrac EH&S software with multi-corrective action functionality

Affygility Solutions, LLC, a global leader in providing environmental, health and safety solutions to the life sciences industry, announced today the launch of its newest version of its environmental, health, and safety software, Affytrac, with multi-corrective action functionality. Users can now create an infinite amount of corrective actions for a single parent issue.

13 Jul 2010

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse.

12 Jul 2010

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, today announced that the Board has approved the scheme of amalgamation and demerger. This is to enable focused growth and value realization across operating entities.

8 Jul 2010

UTHealth Biotechnology Commercialization Center leases over three-quarters of available space

The University of Texas Health Science Center at Houston (UTHealth) announced that its Biotechnology Commercialization Center (BCC) has leased more than three-quarters of its available space to eight Texas-based startups in less than a year. The center's focus is to assist biotech entrepreneurs and small companies with the translation of discoveries into innovative health solutions.

8 Jul 2010

Millipore launches new ProRes-S media for downstream purification of monoclonal antibodies, proteins

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced the launch of its new ProRes-S media. With the addition of ProRes-S media, Millipore's purification suite now provides a complete solution for the downstream purification of monoclonal antibodies and proteins. Developed jointly with The Dow Chemical Company, ProRes-S media offers biopharmaceutical manufacturers greater flexibility and increased throughput in a smaller manufacturing footprint.

8 Jul 2010

BioNeutral, KRP complete manufacturing and distribution agreement

BioNeutral Group Inc., a specialty chemical technology-based life science company, announced today that it completed an agreement with Keystone Research and Pharmaceuticals for its proprietary formulations for use in the Veterinary, Dental and Cosmetic markets. The Terms are being held confidential.

6 Jul 2010

Life science News and Research

Harvard Apparatus/ Hugo Sachs Elektronik business collaborates to develop lung regeneration bioreactor

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Meridian Bioscience completes acquisition of Bioline group of companies

Bionas launches new Bionas adcon reader for impedance-based, cellular analysis

EndoStim raises $6M in Series B equity financing round

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

Millipore Corporation exchanges common stock with Merck

Ligand Pharmaceuticals announces launch of redesigned Web site

Merck acquires Millipore for $7.0 billion

Maven Semantic releases updates to Biotechnology research database

Gerresheimer second-quarter group revenues increase by 6.8%

Zogenix secures $35M financing for commercial launch of SUMAVEL DosePro needle-free delivery system

Cognis exclusively licensed two new active ingredients from IMD

HighRes Biosolutions to provide high-throughput screening automation to Rigel

Affygility Solutions releases new version of Affytrac EH&S software with multi-corrective action functionality

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Jubilant Organosys Board approves amalgamation of SML & PMSL and demerger of APP business

UTHealth Biotechnology Commercialization Center leases over three-quarters of available space

Millipore launches new ProRes-S media for downstream purification of monoclonal antibodies, proteins

BioNeutral, KRP complete manufacturing and distribution agreement

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News